Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.

GUIDANCE:

Quest Diagnostics sees FY2018 EPS of $6.50-$6.70, versus the consensus of $6.61.

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

Earnings Guidance

Quest Diagnostics (DGX) PT Raised to $112 at CitiFebruary 5, 2018 5:15 AM Credit Suisse Assumes Quest Diagnostics (DGX) at NeutralFebruary 2, 2018 7:28 AM Quest Diagnostics (DGX) PT Raised to $110 at SunTrust Robinson HumphreyFebruary 2, 2018 2:48 AM Quest Diagnostics (DGX) Raises Quarterly Dividend 11.1% to $0.50; 1.9% YieldFebruary 1, 2018 7:12 AM Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per QuarterFebruary 1, 2018 6:45 AM